Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jose de Leon

Showing results (11-20 of 380) with videos related to

Pageof 38
Sort By:
Journal of Clinical Psychopharmacology|April 11, 2014
False-negative studies may systematically contaminate the literature on the effects of inducers in neuropsychopharmacology: part II: focus on bipolar disorderJose de Leon
Acta Neuropsychiatrica|December 3, 2014
Focusing on drug versus disease mechanisms and on clinical subgrouping to advance personalised medicine in psychiatryJose de Leon
British Journal of Clinical Pharmacology|September 15, 2022
According to the WHO clozapine pharmacovigilance database, the United Kingdom accounts for 968 fatal outcomes versus 892 in the rest of the worldJose de Leon
Revista De Psiquiatria Y Salud Mental|March 10, 2015
The effects of antiepileptic inducers in neuropsychopharmacology, a neglected issue. Part I: A summary of the current state for cliniciansJose de Leon
The American Journal of Psychiatry|June 2, 2014
Response to GorelickJose de Leon
Acta Neuropsychiatrica|April 8, 2015
Is psychiatry only neurology? Or only abnormal psychology? Déjà vu after 100 yearsJose de Leon
Pharmacogenomics|August 4, 2021
Tools for optimizing pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressantsJose de Leon
Neuropharmacology|June 1, 2019
Personalizing dosing of risperidone, paliperidone and clozapine using therapeutic drug monitoring and pharmacogeneticsJose de Leon
Journal of Clinical Psychopharmacology|May 1, 2014
Paradoxes of US psychopharmacology practice in 2013: undertreatment of severe mental illness and overtreatment of minor psychiatric problemsJose de Leon
The Journal of Clinical Psychiatry|August 25, 2004
Respiratory infections rather than antibiotics may increase clozapine levels: a critical review of the literatureJose de Leon
Pageof 38

Showing results (11-20 of 380) with videos related to

Sort By:
Pageof 38
Journal of Clinical Psychopharmacology|April 11, 2014
False-negative studies may systematically contaminate the literature on the effects of inducers in neuropsychopharmacology: part II: focus on bipolar disorderJose de Leon
Acta Neuropsychiatrica|December 3, 2014
Focusing on drug versus disease mechanisms and on clinical subgrouping to advance personalised medicine in psychiatryJose de Leon
British Journal of Clinical Pharmacology|September 15, 2022
According to the WHO clozapine pharmacovigilance database, the United Kingdom accounts for 968 fatal outcomes versus 892 in the rest of the worldJose de Leon
Revista De Psiquiatria Y Salud Mental|March 10, 2015
The effects of antiepileptic inducers in neuropsychopharmacology, a neglected issue. Part I: A summary of the current state for cliniciansJose de Leon
The American Journal of Psychiatry|June 2, 2014
Response to GorelickJose de Leon
Acta Neuropsychiatrica|April 8, 2015
Is psychiatry only neurology? Or only abnormal psychology? Déjà vu after 100 yearsJose de Leon
Pharmacogenomics|August 4, 2021
Tools for optimizing pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressantsJose de Leon
Neuropharmacology|June 1, 2019
Personalizing dosing of risperidone, paliperidone and clozapine using therapeutic drug monitoring and pharmacogeneticsJose de Leon
Journal of Clinical Psychopharmacology|May 1, 2014
Paradoxes of US psychopharmacology practice in 2013: undertreatment of severe mental illness and overtreatment of minor psychiatric problemsJose de Leon
The Journal of Clinical Psychiatry|August 25, 2004
Respiratory infections rather than antibiotics may increase clozapine levels: a critical review of the literatureJose de Leon
Pageof 38